BCL2L1 and central nervous system cancer: In addition, ABT-737- and HA-14-1-treated glioma-bearing mice showed reduced tumor formation and increased survival, suggesting that targeting Bcl-2/Bcl-xL/Bcl-w alone or in combination with chemotherapy and radiation regimens represents a promising therapeutic approach.